| UniProt ID | ENOF1_HUMAN | |
|---|---|---|
| UniProt AC | Q7L5Y1 | |
| Protein Name | Mitochondrial enolase superfamily member 1 | |
| Gene Name | ENOSF1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 443 | |
| Subcellular Localization | Mitochondrion . | |
| Protein Description | Plays a role in the catabolism of L-fucose, a sugar that is part of the carbohydrates that are attached to cellular glycoproteins. Catalyzes the dehydration of L-fuconate to 2-keto-3-deoxy-L-fuconate by the abstraction of the 2-proton to generate an enediolate intermediate that is stabilized by the magnesium ion. [PubMed: 24697329] | |
| Protein Sequence | MVRGRISRLSVRDVRFPTSLGGHGADAMHTDPDYSAAYVVIETDAEDGIKGCGITFTLGKGTEVVVCAVNALAHHVLNKDLKDIVGDFRGFYRQLTSDGQLRWIGPEKGVVHLATAAVLNAVWDLWAKQEGKPVWKLLVDMDPRMLVSCIDFRYITDVLTEEDALEILQKGQIGKKEREKQMLAQGYPAYTTSCAWLGYSDDTLKQLCAQALKDGWTRFKVKVGADLQDDMRRCQIIRDMIGPEKTLMMDANQRWDVPEAVEWMSKLAKFKPLWIEEPTSPDDILGHATISKALVPLGIGIATGEQCHNRVIFKQLLQAKALQFLQIDSCRLGSVNENLSVLLMAKKFEIPVCPHAGGVGLCELVQHLIIFDYISVSASLENRVCEYVDHLHEHFKYPVMIQRASYMPPKDPGYSTEMKEESVKKHQYPDGEVWKKLLPAQEN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 36 | Ubiquitination | HTDPDYSAAYVVIET CCCCCCCEEEEEEEE | 9.15 | - | |
| 39 | Ubiquitination | PDYSAAYVVIETDAE CCCCEEEEEEEECCC | 2.76 | - | |
| 41 | Ubiquitination | YSAAYVVIETDAEDG CCEEEEEEEECCCCC | 3.17 | - | |
| 41 | Ubiquitination | YSAAYVVIETDAEDG CCEEEEEEEECCCCC | 3.17 | 29967540 | |
| 62 | Ubiquitination | TFTLGKGTEVVVCAV EEEECCCCEEEEEHH | 29.14 | - | |
| 76 | Ubiquitination | VNALAHHVLNKDLKD HHHHHHHHCCCCHHH | 4.53 | 21963094 | |
| 82 | Ubiquitination | HVLNKDLKDIVGDFR HHCCCCHHHHHHHHH | 56.39 | 29967540 | |
| 84 | Ubiquitination | LNKDLKDIVGDFRGF CCCCHHHHHHHHHHH | 3.40 | - | |
| 85 | Ubiquitination | NKDLKDIVGDFRGFY CCCHHHHHHHHHHHH | 9.62 | 29967540 | |
| 90 | Ubiquitination | DIVGDFRGFYRQLTS HHHHHHHHHHHHCCC | 24.75 | 21963094 | |
| 92 | Phosphorylation | VGDFRGFYRQLTSDG HHHHHHHHHHCCCCC | 10.56 | 27134283 | |
| 96 | Phosphorylation | RGFYRQLTSDGQLRW HHHHHHCCCCCCEEE | 19.21 | 27134283 | |
| 97 | Phosphorylation | GFYRQLTSDGQLRWI HHHHHCCCCCCEEEE | 48.62 | 27134283 | |
| 97 | Ubiquitination | GFYRQLTSDGQLRWI HHHHHCCCCCCEEEE | 48.62 | 21963094 | |
| 111 | Ubiquitination | IGPEKGVVHLATAAV ECCCCCHHHHHHHHH | 4.11 | 21963094 | |
| 132 | Ubiquitination | LWAKQEGKPVWKLLV HHHHHCCCCEEEEEE | 35.33 | 29967540 | |
| 133 | Ubiquitination | WAKQEGKPVWKLLVD HHHHCCCCEEEEEEC | 48.32 | 29967540 | |
| 148 | Phosphorylation | MDPRMLVSCIDFRYI CCHHHHHHHEEHHHH | 11.03 | 14702039 | |
| 166 | Ubiquitination | LTEEDALEILQKGQI CCHHHHHHHHHHCCC | 43.29 | - | |
| 170 | Ubiquitination | DALEILQKGQIGKKE HHHHHHHHCCCCHHH | 49.70 | 29967540 | |
| 189 | Ubiquitination | MLAQGYPAYTTSCAW HHHCCCCCEECCCHH | 13.06 | 21963094 | |
| 201 | Ubiquitination | CAWLGYSDDTLKQLC CHHCCCCHHHHHHHH | 44.42 | 21963094 | |
| 206 | Ubiquitination | YSDDTLKQLCAQALK CCHHHHHHHHHHHHH | 44.90 | - | |
| 210 | Ubiquitination | TLKQLCAQALKDGWT HHHHHHHHHHHHCCE | 46.35 | 21963094 | |
| 215 | Ubiquitination | CAQALKDGWTRFKVK HHHHHHHCCEEEEEE | 26.52 | 21963094 | |
| 222 | Ubiquitination | GWTRFKVKVGADLQD CCEEEEEEECCCCHH | 35.23 | 29967540 | |
| 244 | Ubiquitination | IRDMIGPEKTLMMDA HHHHHCCCCEEEECH | 54.16 | 29967540 | |
| 246 | Phosphorylation | DMIGPEKTLMMDANQ HHHCCCCEEEECHHH | 20.44 | - | |
| 254 | Ubiquitination | LMMDANQRWDVPEAV EEECHHHCCCHHHHH | 31.22 | 29967540 | |
| 255 | Ubiquitination | MMDANQRWDVPEAVE EECHHHCCCHHHHHH | 10.94 | 29967540 | |
| 266 | Ubiquitination | EAVEWMSKLAKFKPL HHHHHHHHHHHCCCC | 36.04 | 29967540 | |
| 269 | Ubiquitination | EWMSKLAKFKPLWIE HHHHHHHHCCCCEEC | 65.44 | - | |
| 271 | Ubiquitination | MSKLAKFKPLWIEEP HHHHHHCCCCEECCC | 38.19 | 21963094 | |
| 279 | Phosphorylation | PLWIEEPTSPDDILG CCEECCCCCCCCCCC | 57.05 | 26657352 | |
| 280 | Phosphorylation | LWIEEPTSPDDILGH CEECCCCCCCCCCCC | 36.73 | 28857561 | |
| 286 | Ubiquitination | TSPDDILGHATISKA CCCCCCCCCCHHHHH | 14.55 | 21963094 | |
| 292 | Ubiquitination | LGHATISKALVPLGI CCCCHHHHHHHCCCC | 41.72 | 21963094 | |
| 300 | Phosphorylation | ALVPLGIGIATGEQC HHHCCCCCCCCCCHH | 11.15 | 27251275 | |
| 307 | Ubiquitination | GIATGEQCHNRVIFK CCCCCCHHHHHHHHH | 2.40 | 21963094 | |
| 314 | Ubiquitination | CHNRVIFKQLLQAKA HHHHHHHHHHHHHHH | 28.98 | 21963094 | |
| 334 | Ubiquitination | IDSCRLGSVNENLSV CCCCCCCCCCCCHHH | 26.76 | 21963094 | |
| 340 | Phosphorylation | GSVNENLSVLLMAKK CCCCCCHHHHHHHCC | 23.46 | 29759185 | |
| 382 | Ubiquitination | SVSASLENRVCEYVD HCCHHHHHHHHHHHH | 47.15 | 21963094 | |
| 387 | Phosphorylation | LENRVCEYVDHLHEH HHHHHHHHHHHHHHH | 13.17 | 18452278 | |
| 396 | Ubiquitination | DHLHEHFKYPVMIQR HHHHHHCCCCEEEEE | 51.02 | 21963094 | |
| 397 | Phosphorylation | HLHEHFKYPVMIQRA HHHHHCCCCEEEEEC | 10.50 | 25850435 | |
| 403 | Ubiquitination | KYPVMIQRASYMPPK CCCEEEEECCCCCCC | 17.99 | 21963094 | |
| 405 | Phosphorylation | PVMIQRASYMPPKDP CEEEEECCCCCCCCC | 24.93 | 22985185 | |
| 406 | Phosphorylation | VMIQRASYMPPKDPG EEEEECCCCCCCCCC | 16.80 | 25850435 | |
| 411 | Ubiquitination | ASYMPPKDPGYSTEM CCCCCCCCCCCCCCC | 47.86 | 21963094 | |
| 422 | Phosphorylation | STEMKEESVKKHQYP CCCCCHHHHHHHCCC | 40.09 | 24702127 | |
| 425 | Ubiquitination | MKEESVKKHQYPDGE CCHHHHHHHCCCCCH | 33.51 | 29967540 | |
| 435 | Ubiquitination | YPDGEVWKKLLPAQE CCCCHHHHHHCCCCC | 38.42 | 29967540 | |
| 436 | Ubiquitination | PDGEVWKKLLPAQEN CCCHHHHHHCCCCCC | 39.27 | 29967540 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ENOF1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ENOF1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ENOF1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of ENOF1_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Enhancement of 5-fluorouracil sensitivity by an rTS signaling mimicin H630 colon cancer cells."; Dolnick R., Wu Q., Angelino N.J., Stephanie L.V., Chow K.-C.,Sufrin J.R., Dolnick B.J.; Cancer Res. 65:5917-5924(2005). Cited for: PHOSPHORYLATION AT SER-148, AND SUMOYLATION. | |